Last update: Dec. 19, 2013
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
It is a μ-opioid receptor antagonist that accelerates intestinal transit. Prescribed after intestinal surgery procedures.
Since oral absorption and plasma levels are very low secretion into breast milk is thought to be minimal.
We do not have alternatives for Alvimopan.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM